707 related articles for article (PubMed ID: 33169637)
21. COVID-19 and RAS: Unravelling an Unclear Relationship.
D'Ardes D; Boccatonda A; Rossi I; Guagnano MT; Santilli F; Cipollone F; Bucci M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344526
[TBL] [Abstract][Full Text] [Related]
22. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression.
Huang I; Lim MA; Pranata R
Diabetes Metab Syndr; 2020; 14(4):395-403. PubMed ID: 32334395
[TBL] [Abstract][Full Text] [Related]
23. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
Amor S; Fernández Blanco L; Baker D
Clin Exp Immunol; 2020 Nov; 202(2):193-209. PubMed ID: 32978971
[TBL] [Abstract][Full Text] [Related]
24. What happens to people's lungs when they get coronavirus disease 2019?
Frizzelli A; Tuttolomondo D; Aiello M; Majori M; Bertorelli G; Chetta A
Acta Biomed; 2020 May; 91(2):146-149. PubMed ID: 32420938
[TBL] [Abstract][Full Text] [Related]
25. Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
Pérez-Vizcaíno F
J Heart Lung Transplant; 2020 Oct; 39(10):1167-1169. PubMed ID: 32762876
[No Abstract] [Full Text] [Related]
26. Angiotensin-Converting Enzyme 2 as the Molecular Bridge Between Epidemiologic and Clinical Features of COVID-19.
Bombardini T; Picano E
Can J Cardiol; 2020 May; 36(5):784.e1-784.e2. PubMed ID: 32299780
[No Abstract] [Full Text] [Related]
27. Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?
Peiró C; Moncada S
Circulation; 2020 May; 141(21):1665-1666. PubMed ID: 32242749
[No Abstract] [Full Text] [Related]
28. The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications.
Diamond B
J Exp Med; 2020 Aug; 217(8):. PubMed ID: 32556101
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV2 entry and spread in the lymphatic drainage system of the brain.
Bostancıklıoğlu M
Brain Behav Immun; 2020 Jul; 87():122-123. PubMed ID: 32360606
[No Abstract] [Full Text] [Related]
30. COVID-19 and Multiorgan Response.
Zaim S; Chong JH; Sankaranarayanan V; Harky A
Curr Probl Cardiol; 2020 Aug; 45(8):100618. PubMed ID: 32439197
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 and Severe Obesity: A Big Problem?
Kass DA
Ann Intern Med; 2020 Nov; 173(10):840-841. PubMed ID: 32783685
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia inducible factor-1 protects against COVID-19: A hypothesis.
Afsar B; Kanbay M; Afsar RE
Med Hypotheses; 2020 Oct; 143():109857. PubMed ID: 32464493
[No Abstract] [Full Text] [Related]
33. Risk of COVID-19 for patients with obesity.
Kassir R
Obes Rev; 2020 Jun; 21(6):e13034. PubMed ID: 32281287
[No Abstract] [Full Text] [Related]
34. Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility.
Ji HL; Zhao R; Matalon S; Matthay MA
Physiol Rev; 2020 Jul; 100(3):1065-1075. PubMed ID: 32216698
[TBL] [Abstract][Full Text] [Related]
35. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression.
Pranata R; Lim MA; Huang I; Raharjo SB; Lukito AA
J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926899. PubMed ID: 32408793
[TBL] [Abstract][Full Text] [Related]
36. Hypoxemia in COVID-19 patients: An hypothesis.
Fisher HK
Med Hypotheses; 2020 Oct; 143():110022. PubMed ID: 32634734
[TBL] [Abstract][Full Text] [Related]
37. Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS).
Neubauer A; Wiesmann T; Vogelmeier CF; Mack E; Skevaki C; Gaik C; Keller C; Figiel J; Sohlbach K; Rolfes C; Renz H; Wulf H; Burchert A
Leukemia; 2020 Aug; 34(8):2276-2278. PubMed ID: 32555296
[No Abstract] [Full Text] [Related]
38. The acute respiratory distress syndrome biomarker pipeline: crippling gaps between discovery and clinical utility.
Bime C; Camp SM; Casanova N; Oita RC; Ndukum J; Lynn H; Garcia JGN
Transl Res; 2020 Dec; 226():105-115. PubMed ID: 32599095
[TBL] [Abstract][Full Text] [Related]
39. The Use of Captopril-Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic.
Biyani CS; Palit V; Daga S
Urology; 2020 Jul; 141():182-183. PubMed ID: 32333991
[No Abstract] [Full Text] [Related]
40. COVID-19 pneumonia: phenotype assessment requires bedside tools.
Zhao Z; Kung WH; Chang HT; Hsu YL; Frerichs I
Crit Care; 2020 May; 24(1):272. PubMed ID: 32471449
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
